Research Article
Passiflora cincinnata Extract Delays the Development of Motor Signs and Prevents Dopaminergic Loss in a Mice Model of Parkinson’s Disease
Figure 2
Effects of repeated administration of Passiflora cincinnata extract (25 mg/kg) and reserpine (0.1 mg/kg) on catalepsy behavior of mice. (a) Entire treatment analysis, (b) basal phase, (c) premotor phase, and (d) motor phases. Data are expressed as mean ± SEM. RES/CTR compared to CTR/CTR; RES/PAS compared to CTR/CTR; and RES/CTR compared to RES/PAS (repeated measures ANOVA followed by Tukey’s post hoc test).
(a) |
(b) |
(c) |
(d) |